---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-034156"
form_type: "8-K"
ticker: "MMED"
cik: "0002062583"
company_name: "MiniMed Group, Inc."
filed_at: "2026-03-25T23:59:59+00:00"
generated_at: "2026-05-15T09:07:35.353359+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# MiniMed Flex insulin pump receives FDA clearance months early; $157M charge expected in Q4 FY2026

## Summary
- FDA cleared MiniMed Flex insulin pump several months earlier than expected, enabling earlier commercialization.
- R&D was funded by Blackstone; Blackstone to earn greater of mid-to-high single digit royalty or min $157M payment.
- MiniMed will record a one-time charge of $157 million in Q4 FY2026 for future payments due to Blackstone.
- MiniMed Flex is a next-generation, smartphone-controlled insulin pump with a discreet design.

## SEC filing metadata
- accession: 0001104659-26-034156
- form_type: 8-K
- ticker: MMED
- cik: 0002062583
- company_name: MiniMed Group, Inc.
- filed_at: 2026-03-25T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2062583/000110465926034156/0001104659-26-034156-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2062583/000110465926034156/tm269779d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-034156
- JSON: https://secwatch.observer/filing/0001104659-26-034156.json
- Plain text: https://secwatch.observer/filing/0001104659-26-034156.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.